DK0600010T3 - Anvendelse af relaxin til fremstilling af et medikament til behandling af cardiovaskulære sygdomme - Google Patents

Anvendelse af relaxin til fremstilling af et medikament til behandling af cardiovaskulære sygdomme

Info

Publication number
DK0600010T3
DK0600010T3 DK92918862T DK92918862T DK0600010T3 DK 0600010 T3 DK0600010 T3 DK 0600010T3 DK 92918862 T DK92918862 T DK 92918862T DK 92918862 T DK92918862 T DK 92918862T DK 0600010 T3 DK0600010 T3 DK 0600010T3
Authority
DK
Denmark
Prior art keywords
relaxin
treatment
medicament
manufacture
cardiovascular diseases
Prior art date
Application number
DK92918862T
Other languages
Danish (da)
English (en)
Inventor
Michael Cronin
Phyllis L Osheroff
G Roger Thomas
David G Ward
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/747,080 external-priority patent/US5166191A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0600010T3 publication Critical patent/DK0600010T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92918862T 1991-08-19 1992-08-18 Anvendelse af relaxin til fremstilling af et medikament til behandling af cardiovaskulære sygdomme DK0600010T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/747,080 US5166191A (en) 1991-08-19 1991-08-19 Use of relaxin in cardiovascular therapy
US07/902,637 US5478807A (en) 1991-08-19 1992-06-23 Use of relaxin in the treatment of bradycardia
PCT/US1992/006927 WO1993003755A2 (en) 1991-08-19 1992-08-18 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
DK0600010T3 true DK0600010T3 (da) 2002-07-01

Family

ID=27114692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92918862T DK0600010T3 (da) 1991-08-19 1992-08-18 Anvendelse af relaxin til fremstilling af et medikament til behandling af cardiovaskulære sygdomme

Country Status (11)

Country Link
US (1) US5478807A (de)
EP (1) EP0600010B1 (de)
JP (1) JP3747058B2 (de)
AT (1) ATE214287T1 (de)
AU (1) AU662923B2 (de)
CA (1) CA2114250C (de)
DE (1) DE69232485T2 (de)
DK (1) DK0600010T3 (de)
ES (1) ES2173868T3 (de)
NZ (1) NZ243970A (de)
WO (1) WO1993003755A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2145515A1 (en) * 1993-07-27 1995-02-09 Mario Bigazzi Use of relaxin as therapeutic or preventing agent
US7069634B1 (en) 1995-04-28 2006-07-04 Medtronic, Inc. Method for manufacturing a catheter
US5911997A (en) * 1995-06-07 1999-06-15 Connetics Corporation Relaxin-like factor and methods and uses thereof
US5811395A (en) * 1995-06-07 1998-09-22 Medical University Of South Carolina Relaxin analogs and derivatives methods and uses thereof
US6211147B1 (en) 1995-08-15 2001-04-03 Connetics Corporation Method of promoting angiogenesis using relaxin
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US5846220A (en) * 1996-04-30 1998-12-08 Medtronic, Inc. Therapeutic method for treatment of Alzheimer's disease
US7189222B2 (en) 1996-04-30 2007-03-13 Medtronic, Inc. Therapeutic method of treatment of alzheimer's disease
US6627746B1 (en) 1998-04-17 2003-09-30 Exelixis, Inc. Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
US6251863B1 (en) 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
US6308095B1 (en) 1999-02-12 2001-10-23 Cardiac Pacemakers, Inc. System and method for arrhythmia discrimination
US6266554B1 (en) 1999-02-12 2001-07-24 Cardiac Pacemakers, Inc. System and method for classifying cardiac complexes
US6223078B1 (en) 1999-03-12 2001-04-24 Cardiac Pacemakers, Inc. Discrimination of supraventricular tachycardia and ventricular tachycardia events
US6312388B1 (en) 1999-03-12 2001-11-06 Cardiac Pacemakers, Inc. Method and system for verifying the integrity of normal sinus rhythm templates
US6449503B1 (en) * 1999-07-14 2002-09-10 Cardiac Pacemakers, Inc. Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm
US6684100B1 (en) 2000-10-31 2004-01-27 Cardiac Pacemakers, Inc. Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification
DE10155843A1 (de) * 2000-11-16 2003-01-30 Immundiagnostik Ag Verfahren zur Prognose und Diagnose von Herzinsuffizienz
US20040006205A1 (en) * 2001-04-03 2004-01-08 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6526313B2 (en) 2001-06-05 2003-02-25 Cardiac Pacemakers, Inc. System and method for classifying cardiac depolarization complexes with multi-dimensional correlation
AUPR814401A0 (en) 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
US6950702B2 (en) 2002-07-15 2005-09-27 Cardiac Pacemakers, Inc. Use of curvature based features for beat detection
US7792571B2 (en) 2003-06-27 2010-09-07 Cardiac Pacemakers, Inc. Tachyarrhythmia detection and discrimination based on curvature parameters
US7878978B2 (en) * 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
EP1765149B1 (de) * 2004-03-19 2016-09-28 University Of Pittsburgh Verwendung von relaxin zur erhöhung der arteriencompliance
US7430446B2 (en) 2005-01-20 2008-09-30 Cardiac Pacemakers, Inc. Methods and apparatuses for cardiac arrhythmia classification using morphology stability
WO2006118131A1 (ja) * 2005-04-26 2006-11-09 Eisai R & D Management Co., Ltd. 抗不安作用を有するペプチドおよびスクリーニング方法
US20060264367A1 (en) * 2005-05-21 2006-11-23 Howard Florey Institute Prevention of fibrosis following cardiac injury
US9314210B2 (en) 2005-06-13 2016-04-19 Cardiac Pacemakers, Inc. Method and apparatus for rate-dependent morphology-based cardiac arrhythmia classification
AU2007212110A1 (en) 2006-02-02 2007-08-16 Innovative Bio Therapies An extracorporeal cell-based therapeutic device and delivery system
PL2288373T3 (pl) 2008-05-16 2015-11-30 Corthera Inc Relaksyna do stosowania w leczeniu duszności powiązanej z ostrą niewydolnością serca
WO2010071692A2 (en) 2008-06-18 2010-06-24 Innovative Biotherapies, Inc. Methods for enhanced propagation of cells
US9653006B2 (en) 2008-09-17 2017-05-16 Avery Dennison Corporation Activatable adhesive, labels, and related methods
KR101879190B1 (ko) 2009-09-17 2018-07-17 애버리 데니슨 코포레이션 활성화 가능 접착제, 라벨, 및 관련 방법
WO2024047130A1 (en) 2022-08-31 2024-03-07 Relaxera Pharmazeutische Gesellschaft mbH & Co. KG Immunosuppressive medicament and method of treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656249A (en) * 1982-06-10 1987-04-07 Howard Florey Institute Of Experimental Physiology And Medicine Peptides with relaxin activity
EP0287820B1 (de) * 1982-08-12 1992-07-08 Howard Florey Institute Of Experimental Physiology And Medicine Analoge des humanen Relaxins
AU562962B2 (en) * 1982-08-12 1987-06-25 Howard Florey Institute Of Experimental Physiology And Medicine Molecular cloning and characterisation of the gene sequence coding for human relaxin
DE3236264A1 (de) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg Verfahren zur gewinnung von relaxin
DE3236267A1 (de) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg Verfahren zur herstellung von relaxin und verfahren zur hochreinigung von relaxin
AU562713B2 (en) * 1982-12-13 1987-06-18 Howard Florey Institute Of Experimental Physiology And Medicine Cloning for human relaxin
IL70414A (en) * 1982-12-13 1991-06-10 Florey Howard Inst Polypeptide having human h2-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
US5023321A (en) * 1982-12-13 1991-06-11 Howard Florey Institute Of Experimental Physiology & Medicine Molecular cloning and characterization of a further gene sequence coding for human relaxin
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
JP2815649B2 (ja) * 1988-02-26 1998-10-27 ジェネンテク，インコーポレイテッド ヒトレラキシン製剤
EP0470976B1 (de) * 1989-05-04 1993-03-31 Genentech, Inc. Verfahren und zusammensetzungen zur isolation von menschlichem relaxin
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy

Also Published As

Publication number Publication date
AU2518692A (en) 1993-03-16
JPH06510045A (ja) 1994-11-10
ES2173868T3 (es) 2002-11-01
JP3747058B2 (ja) 2006-02-22
ATE214287T1 (de) 2002-03-15
DE69232485T2 (de) 2002-11-21
AU662923B2 (en) 1995-09-21
US5478807A (en) 1995-12-26
CA2114250A1 (en) 1993-03-04
WO1993003755A3 (en) 1993-04-01
EP0600010B1 (de) 2002-03-13
NZ243970A (en) 1997-06-24
CA2114250C (en) 2007-10-16
EP0600010A1 (de) 1994-06-08
WO1993003755A2 (en) 1993-03-04
DE69232485D1 (de) 2002-04-18

Similar Documents

Publication Publication Date Title
DK0600010T3 (da) Anvendelse af relaxin til fremstilling af et medikament til behandling af cardiovaskulære sygdomme
NO20013727D0 (no) Anvendelse av Botulinumtoksin B for fremstilling av et medikament
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
ITTO920145A0 (it) Valvola multifunzionale per paziente.
DK0659410T3 (da) Anvendelse af det aktive middel flupirtin til fremstilling af et lægemiddel til bekæmpelse af muskelspændinger
KR960702318A (ko) 근육 질병 및 장애의 치료방법
NL7903824A (nl) Samenstelling voor de therapeutische behandeling van chronische uremiepatienten, die periodiek een hemodialyse ondergaan.
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
DK0781560T3 (da) Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse
DE3875675T2 (de) Asymmetrischer s.p.e.c.t.-kollimator, der den patienten umgibt.
DK578887A (da) Antihypertensiva
NO970573L (no) Ylidenforbindelser og deres fremstilling
DK0814791T3 (da) Aminotetralin-derivat til behandlingen af cardiovaskulære sygdomme
DK0768083T3 (da) Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
FI862493A (fi) Fysiologiska medel foer effektivering av transdermal administration av laekemedel.
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
MX9804578A (es) Composiciones consistiendo en bismuto o uno o mas antimicrobianos, para la prevencion y el tratamiento de trastornos gastrointestinales.
DK0429324T3 (da) Anvendelse af N-methyl-2-(3pyridyl)-tetrahydrothiopyran-2-carbothioamid-1-oxid til fremstilling af lægemidler beregnet til behandling af coronarinsufficiens
IT8125670A0 (it) Poltrona odontoiatrica per paziente.
WO1997004790A3 (de) Arzneimittel zur behandlung von ulcera welches magnesiumionen als wirksubstanz umfasst
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses